FDA Inspection 1126291 — Janssen Biologics B.V.

Janssen Biologics B.V. — FEI 3002806632

The FDA completed an inspection of Janssen Biologics B.V. on Oct 11, 2018 in Leiden. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.